Fate Therapeutics (FATE) Long-Term Debt Repayments (2013 - 2019)

Fate Therapeutics has reported Long-Term Debt Repayments for 6 years, with the latest figure at $14.0 million in Q4 2019.

• For the quarter ending Q4 2019, Long-Term Debt Repayments changed N/A year-over-year to $14.0 million; the trailing twelve-month figure through Dec 2019 stood at $22.7 million (changed N/A YoY), and the FY2019 full-year result was $15.0 million, changed N/A from the prior year.
• Long-Term Debt Repayments for Q4 2019 stood at $14.0 million, up from $6.7 million in the prior quarter.
• The five-year high for Long-Term Debt Repayments was $14.0 million in Q4 2019, with the low at $600000.0 in Q3 2015.
• Historically, Long-Term Debt Repayments has averaged $3.4 million across 4 years, with a median of $1.9 million in 2016.
• Annual changes were most pronounced in 2015 — Long-Term Debt Repayments declined 20.0% — and 2017, when it jumped 253.11%.
• Fate Therapeutics' Long-Term Debt Repayments stood at $935000.0 in 2015, then surged by 111.23% to $2.0 million in 2016, then jumped by 239.7% to $6.7 million in 2017, then surged by 108.67% to $14.0 million in 2019.
• The last three Long-Term Debt Repayments figures came in at $14.0 million (Q4 2019), $6.7 million (Q3 2017), and $2.0 million (Q2 2017), per Business Quant data.